Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01667666 · ClinicalTrials.gov registry record · Phase 1
Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
A Phase 1 study, sponsored by Denver Health and Hospital Authority.
- Terminated
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01667666 is a Phase 1 study that was terminated before completion, run by Denver Health and Hospital Authority. The registered enrollment target is 13 participants.
The verdict
NCT01667666, a Phase 1 study, was terminated before completion, sponsored by Denver Health and Hospital Authority.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study evaluates the use of nebulized hypertonic saline (aerosolized salt water) as a preventive treatment for post-traumatic acute lung injury (ALI). Both animal and human research indicate that aerosolized salt water might help reduce harmful inflammation with minimal risks.
Interventions
- DRUG Nebulized hypertonic saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-11-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01667666
The ClinicalTrials.gov registry entry for NCT01667666 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nebulized hypertonic saline is the first listed.
NCT01667666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01667666 about?
NCT01667666 is a clinical study titled "Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury". This study evaluates the use of nebulized hypertonic saline (aerosolized salt water) as a preventive treatment for post-traumatic acute lung injury (ALI). Both animal and human research indicate that aerosolized salt water might help reduce harmful inflammation with minimal risks.
What is the current status of trial NCT01667666?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2012-05. Estimated completion is 2018-11-06.
What interventions are being tested in trial NCT01667666?
The interventions under investigation include: Nebulized hypertonic saline (DRUG).
Who is sponsoring clinical trial NCT01667666?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.